Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Ark Foundation Stories

2011-11-09 04:07:00

LAUSANNE, Switzerland, November 9, 2011 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group with a focus on drug development and companion diagnostics, presents the 2011 'Debiopharm /Valais Award' to Augurix Diagnostics (Augurix), a privately held company based in Monthey (Valais), that focuses on point-of-care testing in the field of gastro-enterology and initially on Celiac disease. Debio R.P., the Martigny-based structure of...

2010-11-23 08:00:00

LAUSANNE, Switzerland, November 23, 2010 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), an independent specialist in global bio-pharmaceutical development in the field of oncology and regarding certain serious diseases, has announced the winner of the Prix Debiopharm Valais pour les Sciences de la Vie (Debiopharm Valais Life Sciences Prize). This year, Abionic S.A., represented by its founder and executive director Dr Nicolas Durand, won the prize for a new diagnostic platform, the...